Galleon Pharmaceuticals, Inc. Names Lynne Brookes Senior Vice President and Chief Business Officer
12/1/2011 10:18:17 AM
HORSHAM, Pa.--(BUSINESS WIRE)--Galleon Pharmaceuticals, a leader in the development of novel medicines to treat breathing-control disorders, today announced the appointment of Lynne M. Brookes as senior vice president and chief business officer. She joins Galleon from Cephalon, Inc. where she held a variety of product management, marketing and business development positions and was most recently vice president of business development. She joined Cephalon in 1995 as a product manager and was responsible for commercializing many of Cephalon’s pharmaceutical products including PROVIGIL, the company’s most successful drug.
comments powered by